KMS Medisurgi Ltd
₹ 139
4.97%
12 Nov
- close price
About
Incorporated in 2016, KMS Medisurgi Ltd operates in the manufacturing of Surgical Equipment.[1]
Key Points
- Market Cap ₹ 46.0 Cr.
- Current Price ₹ 139
- High / Low ₹ 139 / 126
- Stock P/E 184
- Book Value ₹ 25.2
- Dividend Yield 0.04 %
- ROCE 5.20 %
- ROE 3.05 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 5.54 times its book value
- The company has delivered a poor sales growth of 10.2% over past five years.
- Company has a low return on equity of 5.02% over last 3 years.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Upcoming result date: tomorrow
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.89 | 8.41 | 7.90 | 7.32 | 9.86 | 10.34 | 7.51 | 10.32 | 11.03 | 13.88 | 13.94 | 12.21 | |
| Sales growth | +16.67% | -5.40% | -6.06% | -7.34% | +34.70% | +4.87% | -27.37% | +37.42% | +6.88% | +25.84% | +0.43% | -12.41% |
| 8.17 | 7.59 | 6.95 | 6.85 | 9.56 | 9.68 | 7.01 | 9.79 | 10.07 | 13.03 | 12.99 | 11.28 | |
| Operating Profit | 0.72 | 0.82 | 0.95 | 0.47 | 0.30 | 0.66 | 0.50 | 0.53 | 0.96 | 0.85 | 0.95 | 0.93 |
| OPM % | 8.10% | 9.75% | 12.03% | 6.42% | 3.04% | 6.38% | 6.66% | 5.14% | 8.70% | 6.12% | 6.81% | 7.62% |
| 0.04 | 0.06 | 0.17 | 0.35 | 0.42 | 0.00 | 0.10 | 0.05 | 0.02 | 0.03 | 0.03 | 0.01 | |
| Interest | 0.27 | 0.24 | 0.27 | 0.19 | 0.09 | 0.07 | 0.03 | 0.00 | 0.00 | 0.02 | 0.10 | 0.14 |
| Depreciation | 0.41 | 0.34 | 0.49 | 0.45 | 0.43 | 0.41 | 0.33 | 0.29 | 0.32 | 0.25 | 0.27 | 0.47 |
| Profit before tax | 0.08 | 0.30 | 0.36 | 0.18 | 0.20 | 0.18 | 0.24 | 0.29 | 0.66 | 0.61 | 0.61 | 0.33 |
| Tax % | 50.00% | 53.33% | 38.89% | 50.00% | 40.00% | 38.89% | 45.83% | 24.14% | 13.64% | 24.59% | 27.87% | 27.27% |
| 0.03 | 0.14 | 0.21 | 0.10 | 0.12 | 0.11 | 0.12 | 0.22 | 0.57 | 0.45 | 0.44 | 0.25 | |
| EPS in Rs | 0.30 | 0.58 | 0.88 | 0.30 | 0.36 | 0.33 | 0.36 | 0.67 | 1.73 | 1.36 | 1.33 | 0.76 |
| Dividend Payout % | 0.00% | 25.71% | 5.71% | 16.50% | 13.75% | 15.00% | 13.75% | 7.50% | 2.89% | 3.67% | 3.75% | 6.60% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 10% |
| 3 Years: | 3% |
| TTM: | -12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 16% |
| 3 Years: | -24% |
| TTM: | -43% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 33% |
| 3 Years: | 12% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 5% |
| 3 Years: | 5% |
| Last Year: | 3% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.50 | 1.20 | 2.40 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 |
| Reserves | 0.64 | 2.13 | 1.12 | 2.85 | 2.95 | 3.05 | 3.15 | 3.37 | 3.93 | 4.36 | 4.79 | 5.01 |
| 2.85 | 2.13 | 2.73 | 1.91 | 1.13 | 1.11 | 1.03 | 0.99 | 0.99 | 0.54 | 0.91 | 0.77 | |
| 3.21 | 2.60 | 2.36 | 2.14 | 3.15 | 1.64 | 1.86 | 2.17 | 1.51 | 2.65 | 1.34 | 1.47 | |
| Total Liabilities | 7.20 | 8.06 | 8.61 | 10.20 | 10.53 | 9.10 | 9.34 | 9.83 | 9.73 | 10.85 | 10.34 | 10.55 |
| 2.25 | 1.98 | 2.69 | 2.25 | 2.20 | 1.81 | 1.65 | 1.48 | 1.82 | 1.65 | 1.68 | 2.93 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 4.95 | 6.08 | 5.92 | 7.95 | 8.33 | 7.29 | 7.69 | 8.35 | 7.91 | 9.20 | 8.66 | 7.62 | |
| Total Assets | 7.20 | 8.06 | 8.61 | 10.20 | 10.53 | 9.10 | 9.34 | 9.83 | 9.73 | 10.85 | 10.34 | 10.55 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.35 | -0.24 | 0.90 | -1.57 | 0.75 | -0.84 | 0.53 | -0.07 | 0.46 | 1.21 | 0.74 | 1.51 | |
| 0.05 | -0.03 | -1.10 | 0.11 | -0.31 | 0.01 | -0.10 | -0.12 | -0.66 | -0.51 | -0.96 | -0.61 | |
| -1.41 | 1.13 | 1.75 | 1.57 | -0.81 | -0.06 | -0.11 | -0.02 | -0.01 | -0.47 | 0.27 | -0.26 | |
| Net Cash Flow | -0.01 | 0.86 | 1.56 | 0.10 | -0.37 | -0.88 | 0.32 | -0.21 | -0.21 | 0.23 | 0.05 | 0.64 |
| Free Cash Flow | 1.40 | -0.31 | -0.29 | -1.58 | 0.36 | -0.86 | 0.36 | -0.19 | -0.20 | 1.09 | 0.44 | -0.21 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 188% | -18% | 106% | -309% | 250% | -129% | 108% | 0% | 59% | 173% | 96% | 171% |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 128.10 | 163.19 | 185.73 | 233.36 | 186.94 | 194.15 | 305.22 | 231.31 | 216.42 | 152.00 | 111.02 | 96.26 |
| Inventory Days | 50.02 | 17.78 | 6.24 | 85.34 | 82.27 | 62.14 | 45.45 | 42.45 | 70.96 | 87.18 | 105.11 | |
| Days Payable | 155.51 | 141.02 | 139.76 | 134.58 | 134.09 | 70.42 | 100.27 | 58.60 | 85.22 | 41.17 | 52.14 | |
| Cash Conversion Cycle | 22.61 | 39.94 | 52.21 | 184.13 | 135.12 | 185.86 | 305.22 | 176.49 | 200.27 | 137.74 | 157.03 | 149.23 |
| Working Capital Days | 21.76 | 30.81 | 9.24 | 158.07 | 148.07 | 188.85 | 253.22 | 200.54 | 199.54 | 153.84 | 144.01 | 142.59 |
| ROCE % | 7.70% | 11.43% | 10.76% | 5.17% | 3.76% | 3.37% | 3.61% | 3.83% | 8.31% | 8.40% | 8.26% | 5.20% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Indigenous Raw Material Consumption Share % |
|
||||||||||
| Permanent Employees count |
|||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday, November 14, 2026
- Board meeting on 14 Nov 2026 to approve half-year unaudited results; trading window already closed.
-
Non-Applicability Of Report On Corporate Governance Pursuant To Regulation 27(2) Of The SEBI (LODR) Regulations, 2015.
- Company states corporate governance report is not applicable for quarter ended 30 September 2026.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Regulation 74(5) certificate for quarter ended 30 September 2026; no rematerialisation requests received.
-
Announcement under Regulation 30 (LODR)-Cessation
- Mr. Hardik Rajnikant Bhatt ceased as Independent Director on September 30, 2026 after completing second term.
-
Announcement under Regulation 30 (LODR)-Cessation
- Mr. Kamlesh Rajani Chunilal ceased as Independent Director on September 30, 2026 after completing second term.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
Business Overview:[1]
KMSML manufactures & undertakes job work of coating of various substrates like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with the adhesive. It is engaged in the business of ethical marketing and distribution of
Surgical Disposable, Haemostat, Medical
Devices, Urology Equipment, Surgery Equipment, Orthopedic /Physiotherapy Equipment, Blood Banking Equipment’s and other such Surgical Equipment in India.